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Abstract
Background:  Cystathionine  β-synthase (CBS) mediates conversion of homocysteine to cystathionine and
deficiency in enzyme activity may lead to hyperhomocysteinemia/homocystinuria, which are often associated with
mental retardation (MR). A large number of polymorphisms have been reported in the CBS gene, some of which
impair its activity and among these, a T833C polymorphism in cis with a 68 bp insertion at 844 in the exon 8 is
found to be associated with mild hyperhomocysteinemia in different ethnic groups.
Methods: The present study is aimed at investigating the association between T833C/844ins68 polymorphism
and MR. One hundred and ninety MR cases were recruited after psychometric evaluation. Hundred and thirty-
eight control subjects, two hundred and sixty-seven parents of MR probands and thirty cardiovascular disorder
(CVD) patients were included for comparison. Peripheral blood was collected after obtaining informed written
consent. The T833C/844ins68 polymorphism was investigated by PCR amplification of genomic DNA and
restriction fragment length polymorphism analysis, followed by statistical analysis.
Results: The genotypic distribution of the polymorphism was within the Hardy-Weinberg equilibrium. A slightly
increased genotypic frequency was observed in the Indian control population as compared to other Asian
populations. Both haplotype-based haplotype relative risk analysis and transmission disequilibrium test reveled
lack of association of the T833C/844ins68 polymorphism with MR; nevertheless, the relative risk calculated was
higher (>1) and in a limited number of informative MR families, preferential transmission of the double mutant
from heterozygous mothers to the MR probands was noticed (χ2 = 4.00, P < 0.05).
Conclusion: This is the first molecular genetic study of CBS gene dealing with T833C/844ins68 double mutation
in MR subjects. Our preliminary data indicate lack of association between T833C/844ins68 polymorphism with
MR. However, higher relative risk and biased transmission of the double mutation from heterozygous mothers
to MR probands are indicative of a risk of association between this polymorphism with mental retardation.
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Background
Cystathionine β-synthase (CBS) catalyzes the condensa-
tion of serine and homocysteine to form cystathionine
and abnormality in CBS activity is manifested in two
major clinical conditions, viz. hyperhomocysteinemia
and homocystinuria. Insufficiency in CBS activity may
lead to hyperhomocysteinemia [1], which is considered to
be an independent risk factor for arteriosclerosis [2]. In
addition to that, since homocysteine is vasculotoxic as
well as neurotoxic, hyperhomocysteinemia predisposes to
cardiovascular disorder (CVD) and cognitive dysfunction
[3,4]. On the other hand, gross deficiency in CBS activity
is associated with homocystinuria, an inborn recessive
metabolic disorder [4]. The major pathologic abnormali-
ties associated with homocystinuria include thromboem-
bolism, ectopia lentis, osteoporosis, mental retardation
(MR) and other neurological and psychiatric abnormali-
ties [4]. The neurological malfunctioning can be ascribed
to the oxidation of excess homocysteine to homocysteic
acid, which interacts with the N-methyl-D-aspartate
receptor, causing excessive calcium influx and free radical
production, thereby leading to neurotoxicity [5]. In addi-
tion, MR associated with B12 and folate deficiency could
be attributed to the neurotoxic effects of homocysteine
since B12 and folate act as co-factors in the homocysteine
to methionine remethylation pathway.
The human CBS gene, located at 21q22.3 [6], is known to
have a large number of mutations, the majority of which
are missense in nature [7]. Three different nonsense
mutants, as well as some insertion, deletion and splice
variants have also been identified, some of which are pol-
ymorphic in nature. A transition mutation, T833C gener-
ating a BsrI restriction site [8,9] is known to segregate in
cis with 844ins68 mutation in exon 8 [10] and is reported
to be associated with premature occlusive arterial disease
[11]. Ethnic heterogeneity of 844ins68 polymorphism is
highly prevalent in African, European and North Ameri-
can populations [9,12,13].
Since the T833C/844ins68 double mutation was not
detected by Franco et al. [13] and Pepe et al. [14] in their
studies on some Asian populations (Japanese, Tharu, Chi-
nese and Indonesian), this allele has been projected by
Pepe et al. [14] as a reliable anthropogenetic marker for
discriminating between two major human groups – Afri-
cans and Asians. Later on, the 844ins68 variant was
observed in Han Chinese population with a very low fre-
quency [15]; however, the T833C polymorphism was not
studied. In India, study on T833C mutation revealed
4.76% and 9.99% heterozygotes in control and coronary
heart disease patients respectively [16]. In the present
study, we have looked into the frequency of the double
mutant in control population. We have also investigated
the occurrence of this double mutant in MR individuals
and a small subset of CVD patients, since hyperhomo-
cysteinemia/homocystinuria is often associated with MR
as well as CVD [4]. Familial transmission pattern of the
double mutation was analyzed, by haplotype-based hap-
lotype relative risk analysis (HHRR) and transmission dis-
equilibrium test (TDT), using heterozygous parents only.
Methods
Study design
Our study population consisted of 138 healthy control
individuals, 30 CVD patients (average age 53.5 yrs) and
190 MR children (age range 6–8 yrs) along with their par-
ents. The cardiologist (J.M) involved in the study helped
in collection of samples from CVD patients. MR cases
were selected from the Outpatient Department of Mano-
vikas Kendra Rehabilitation and Research Institute, Kolk-
ata and diagnosed by mental health professionals (child
psychiatrist, child psychologist and neurologist) accord-
ing to the DSM – IV [17] followed by an IQ assessment
with Wechsler Intelligence Scale for Children [18]. Both
patients and controls were from different parts of India
and belonged to no particular ethnic group. Peripheral
blood was collected in EDTA, after obtaining informed
written consent from control individuals, CVD patients,
Representation of double mutation in exon 8 of CBS gene Figure 1
Representation of double mutation in exon 8 of CBS 
gene: lane 1 = homozygous genotype without insertion, lane 
2 = heterozygous genotype with 68 bp insertion, lane 3 = 
φX174 HaeIII digest showing bands at 310, 281, 234,194 and 
118 respectively, lane 4 = BsrI digestion of heterozygous 
PCR product (of lane 2), showing complete digestion of the 
higher allele of 239 bp into 130 bp and 109 bp.Behavioral and Brain Functions 2005, 1:25 http://www.behavioralandbrainfunctions.com/content/1/1/25
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and parents of MR probands. Genomic DNA was isolated
by standard high salt precipitation method [19]. The
Human Ethical Committee of the Institute approved the
study protocol.
PCR amplification
The primer sequence to amplify the 844ins68 polymor-
phism in the exon 8 and flanking intron 7 of the CBS gene
were: sense, 5'-GTTGTTAACGGCGGTATTGG-3', and anti-
sense, 5'- GTTGTCTGCTCCGTCTGGTT-3'. PCR amplifica-
tion was carried out using Perkin Elmer thermal cycler
(Gene Amp #2400) in a reaction volume of 20 µL contain-
ing 75–100 ng of genomic DNA, 20 pmoles of each
primer, 1.0 U Taq polymerase (Bangalore Genei, India),
200 µM dNTP mix, 0.001% gelatin and 10 mM Tris buffer
(Bangalore Genei, India) with 50 mM KCl and 1.0 mM
MgCl2. After an initial denaturation at 95°C for 3 min,
amplification was performed at: 35 cycles of denaturation
at 94°C for 45 sec, annealing at 58°C for 40 sec and exten-
sion at 72°C for 40 sec, followed by a final extension for
5 min at 72°C. PCR products were separated by 12% poly-
acrylamide gel electrophoresis at 200V for 3 hrs, stained
with ethidium bromide and documented in a Gel Doc™
EQ (BIO-RAD). The wild type allele gave 171 bp fragment
(A1), and insertion variant gave 239 bp fragment (A2)
(Fig. 1).
Restriction fragment length polymorphism (RFLP) analysis
BsrI digestion was carried out for all samples to detect
T833C mutation [9]. PCR products (3 µL) were digested at
65°C for 3 hrs. in a final reaction volume of 25 µL, con-
taining 1 U of BsrI (New England Biolabs; NEB) and NEB
Buffer 4. Since this point mutation occurs in cis  with
844ins68, only the higher allele of 239 bp (A2) was
cleaved by BsrI yielding two fragments of 130 bp and 109
bp respectively (Fig 1); wild type allele of 171 bp (A1),
however, remained undigested.
Statistical analysis
Frequency of the T833C/844ins68 polymorphism in the
control population and patients was calculated for the
Hardy-Weinberg equilibrium. Haplotype-based haplo-
type relative risk (HHRR) analysis [20] as well as transmis-
sion disequilibrium test (TDT) [21] was used to ascertain
association between MR and transmission of the double
mutation. For TDT, trios with at least one parent having
heterozygous genotype were selected.
Results
Distribution of 844ins68 heterozygote in various control
populations studied worldwide is presented in Table I. It
was reported earlier that this variant is absent in the Asian
population [13,14]. Later studies involving larger sample
size revealed the occurrence of 844ins68 variant in the
Chinese population [15,25] with a very low frequency of
Table 1: Global variation of CBS 844ins68 polymorphism in control individuals.
Population 2n Heterozygosity (%) Reference
US (mixed) 144 11.7 Tsai et al. [9]
Dutch 214 14 Kluijtmans et al. [22]
Japanese 80 0.00 Franco et al. [13]
Chinese 26 0.00 Pepe et al. [14]
Indonesian 98 0.00 Pepe et al. [14]
Ethiopian 108 11.11 Pepe et al. [14]
Spanish 54 25.9 Pepe et al. [14]
Sub-Saharan African 180 66.66 Pepe et al. [14]
German 400 1.5 Linnebank et al. [23]
Chinese (Southern China) 200 5 Zhang & Dai [15]
Italian 820 13.7 Grossmann et al. [24]
Chinese (Northern China) 248 2.97 Li et al. [25]
Indian 276 7.97 Present study
2n = No. of chromosomes
Table 2: Distribution of CBS T833C/844ins68 polymorphism in different groups.
Groups No of chromosome No of mutants Mutant allele frequency ± SE
Control 276 11 0.0398 ± 0.0117
CVD Patients 60 1 0.0166 ± 0.0166
MR probands 380 12 0.0316 ± 0.0089
Parents of probands 534 15 0.028 ± 0.0071Behavioral and Brain Functions 2005, 1:25 http://www.behavioralandbrainfunctions.com/content/1/1/25
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heterozygote as compared to the European and African
subjects. We have analyzed the 844ins68 variant in asso-
ciation with the T833C mutation and our data showed a
higher rate of occurrence of the double mutant in the
Indian control population (7.97%) as compared to the
Chinese population.
Frequency of the double mutant allele in different types of
subjects is presented in Table II. Eleven out of 138 control
individuals (n = 276) appeared heterozygous for the
mutation. On the contrary, only one person out of 30
CVD patients showed heterozygous genotype. In the MR
group, 12 out of 190 MR probands showed presence of
the polymorphism and no significant deviation in allele
frequencies was noted in the MR probands and their par-
ents (Table II).
HHRR analysis for the T833C/844ins68 polymorphism
showed lack of significant association between MR and
transmission of the double mutant (χ2  = 1.714, P  =
0.1905) (Table III). TDT analysis also revealed lack of
association between the T833C/844ins68 polymorphism
and MR (χ2 = 1.00, P  = 0.3173) (Table III). However,
transmission from the mother (Table IV), heterozygous
for the alleles, revealed that the A2 allele was preferen-
tially transmitted to the MR probands (χ2 = 4.00, P  =
0.0455), while no significant contribution of the paternal
allele was noticed (data not presented).
Discussion
The present finding of 11 out of 138 Indian control indi-
viduals with the T833C/844ins68 polymorphism reveal a
higher percentage of heterozygotes (7.97%) as compared
to the Chinese control population (Table I); but, this
value is significantly lower than those quoted for Sub-
Saharan population [14]. Two earlier independent studies
on Japanese and other Asian populations failed to detect
the mutated allele [13,14] and this led to the proposal
that this unique double mutation could be used as a reli-
able anthropogenetic marker for differentiating Asians
and Africans. However, the validity of the proposal is
questioned by subsequent findings of the 844ins68 poly-
morphism in different Chinese populations [15,25] and
T833C transition mutation in Indian population [16,26].
The present study clearly demonstrates that the T833C/
844ins68 polymorphism may not be suitable as an
anthropogenetic marker for differentiating Asians and
Africans.
Among Indians, presence of T833C heterozygote has been
reported in 1 out of 21 (4.76%) [16] and 3 out of 100
(3%) [26] control individuals. However, in both studies
the association of 844ins68 mutation with the T833C
transition mutation has not been mentioned, while in the
present investigation we have observed invariable segrega-
tion of these two mutations in cis, which is consistent with
earlier observations [10,13,14,22].
Hyperhomocysteinemia is hypothesized as an independ-
ent risk factor for CVD [22,27] and the 844ins68 variant
was previously reported to be associated with premature
occlusive arterial disease [11]. A recent article on Chinese
congenital heart disease (CHD) patients have shown that
the 844ins68 could be a risk factor for CHD, and the inser-
tion especially in mothers could increase the risk in off-
spring [25]. On the other hand, the findings of Zhang and
Dai [15] on adult Chinese patients have suggested that the
844ins68 could provide protection to vascular throm-
boembolic disease. The mutant allele frequencies among
the Indian controls and the CVD patients are 0.0398 and
Table 3: HHRR and TDT Analysis for the CBS T833C/844ins68 polymorphism in nuclear families with MR probands.
Allele Transmitted Non-transmitted χ2 P value Relative risk (RR)
HHRR analysis 1 259 264 1.714 0.1905 1.346
21 05
TDT analysis 1 3 6 1.00 0.3173
263
Table 4: Transmission pattern of CBS T833C/844ins68 from mother to MR proband.
Allele Transmitted Non-transmitted χ2 P value
HHRR analysis (all 
mothers)
1 176 180 2.0449 0.1527
262
HHRR analysis 
(heterozygous 
mothers only)
1 2 6 4.00 0.0455
262Behavioral and Brain Functions 2005, 1:25 http://www.behavioralandbrainfunctions.com/content/1/1/25
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0.0166 respectively (Table II) and no association was
observed between T833C/844ins68 polymorphism and
CVD. Heterozygous T833C/844ins68 alleles were
observed at higher percentage in Indian CVD patients
(3.33%) as compared to Chinese ischemic patients
(~1%). The lower value of 3.33% for CVD patients as
compared to that of the control (7.97%) seems to support
the idea of a possible protective role of the double muta-
tion to vascular thromboembolic disease, as proposed by
Zhang and Dai [15]; however, such a conclusion is not
called for due to the relatively small CVD sample size in
the present study.
While the T833C mutation results in Ile278Thr change in
the mutant protein, in the case of T833C/844ins68, the 68
bp insertion results in an alternative splice site generating
mostly wild type mRNA with traces of another transcript,
detectable only in the nucleus [9,12]. This accounts for the
rescue of the transition mutation at 278 in the case of the
double mutant [9,10]. However, these observations can-
not account for the conflicting reports on the association
between cardiovascular disease in different ethnic popula-
tions and the mutant allele [28,29]. Case control studies
showed that this double mutation might be a neutral pol-
ymorphism in the CBS gene and splicing of the intron 7
eliminates the mutant allele carrying the T833C [22]. On
the other hand, in Northern Europe, the T833C mutation
is common in patients presenting clinically with homo-
cystinuria and is associated with a B6-responsive pheno-
type [22,28].
The  CBS  T833C/844ins68 polymorphism has been
reported in homozygous condition, with a very low fre-
quency, from American black artheroslerosis patients [9].
We have failed to observe any subject homozygous for the
mutation in our study group, which possibly points
towards the deleterious effect of this mutation in
homozygous condition.
The present finding of preferential transmission of
T833C/844ins68 polymorphism to the MR proband from
the heterozygous mother is the first evidence of any asso-
ciation of CBS gene with MR, although the association of
hyperhomocysteinemia/homocystinuria with psychiatric
manifestations including MR is well established [3,4,30].
Among different markers for cobalamine/folate status,
plasma homocysteine showed the best association with
aging related neuropsychiatric dysfunction [31] and an
earlier investigation revealed that the CBS 844ins68 allele
frequency was lower in children with high IQ as com-
pared to those with average IQ [32]. In the present inves-
tigation, though the HHRR and TDT analysis failed to
show any significant transmission of the mutant allele to
the MR probands (χ2 = 1.714 and 1.00 respectively), the
relative risk (RR = 1.346) calculated showed a risk of MR
associated with transmission of the mutant allele. The
preferential transmission of T833C/844ins68 polymor-
phism from the heterozygous mother to the MR proband
(χ2 = 4.00, P = 0.0455) also supports the above possibility.
Conclusion
This is the first report on CBS T833C/844ins68 polymor-
phism in association with MR and to the best of our
knowledge, this is also the first information on the occur-
rence of the CBS double mutation in the Indian popula-
tion. Our preliminary data indicate lack of significant
association between T833C/844ins68 polymorphism
with MR; however, the relative risk calculated and the
preferential transmission of the double mutation from
informative mothers to MR probands do suggest a risk of
association of this polymorphism with MR and warrants
further investigation.
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